1-4 of 4
Francisco Vega
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Cumulative Dose of Brentuximab Vedotin on Outcomes of Frontline Therapy for Advanced Stage Hodgkin Lymphoma

Clinical Trials & Observations
Raphael E. Steiner, Steven R Hwang, Arushi Khurana, Thomas M Habermann, Narendranath Epperla, Kaitlin Annunzio, Pamela Blair Allen, Katelin Baird, Darina Paulino, Juan Pablo Alderuccio, Izidore S Lossos, Kevin A. David, Andrew M Evens, Karan Pandya, Steven M. Bair, Manali Kamdar, Sheeba H Ba Aqeel, Pallawi Torka, Ryan C Lynch, Stephen D Smith, Lei Feng, Mansoor Noorani, Sairah Ahmed, Ranjit Nair, Francisco Vega, Susan Wu, Penny Q. Fang, Chelsea C Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Hun Ju Lee
Journal: Blood Advances
Blood Adv bloodadvances.2023010700.
https://doi.org/10.1182/bloodadvances.2023010700
Published: 2023
Includes: Supplemental data
Journal Articles

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

Clinical Trials & Observations
Hua-Jay J. Cherng, Stefan K. Alig, Yasuhiro Oki, Loretta J. Nastoupil, Luis Fayad, Sattva S. Neelapu, Francesco Turturro, Fredrick Hagemeister, Alexander F. M. Craig, Charles W. Macaulay, Maria Alma Rodriguez, Hun Ju Lee, Timothy J. McDonnell, Christopher R. Flowers, Francisco Vega, Michael R. Green, Lei Feng, David M. Kurtz, Ash A. Alizadeh, R. Eric Davis, Jason R. Westin
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1137–1145.
https://doi.org/10.1182/bloodadvances.2022008174
Published: 2023
Journal Articles

SIRPα + macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab

Mario L. Marques-Piubelli, Edwin R. Parra, Lei Feng, Luisa Solis Soto, Mariana Gallardo, Sushanth Gouni, Felipe Samaniego, Mansoor Noorani, Fredrick B. Hagemeister, Jason R. Westin, Hun Ju Lee, Maria A. Rodriguez, Sattva S. Neelapu, Jillian R. Gunther, Nathan H. Fowler, Christopher R. Flowers, Ignacio I. Wistuba, Loretta J. Nastoupil, Francisco Vega, Paolo Strati
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3286–3293.
https://doi.org/10.1182/bloodadvances.2022007104
Published: 2022
Includes: Supplemental data
Journal Articles

CRISPR genome editing of murine hematopoietic stem cells to create Npm1-Alk causes ALK + lymphoma after transplantation

Soumya Sundara Rajan, Lingxiao Li, Mercedes F. Kweh, Kranthi Kunkalla, Amit Dipak Amin, Nitin K. Agarwal, Francisco Vega, Jonathan H. Schatz
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1788–1794.
https://doi.org/10.1182/bloodadvances.2018025247
Published: 2019
Includes: Supplemental data